Method of Treatment
AssigneeGlaxo Group Limited
InventorsKevin Lee, David Francis Tough
Life of this patent
Estimating the term…
Abstract
A method of treating autoimmune and inflammatory diseases or conditions in a mammal, such as a human, which comprises the administration of a inhibitor of the bromodomain-containing protein: SP110
Claims6
A method of treating autoimmune and inflammatory diseases and conditions which comprises inhibiting the bromodomain-containing protein SP110 in a mammal.
A method of treating autoimmune and inflammatory diseases or conditions in a mammal, such as a human, which comprises the administration of a therapeutically effective amount of an inhibitor of the bromodomain-containing protein SP110.
(canceled)
(canceled)
A pharmaceutical formulation for use in the treatment of autoimmune and inflammatory diseases or conditions, comprising an inhibitor of the bromodomain-containing protein SP110, together with at least one pharmaceutical carrier.
A method for identifying compounds that will be useful in treating autoimmune and inflammatory diseases or conditions comprising the step of determining whether the compound inhibits or the step of determining whether the compound activates the bromodomain-containing protein SP110.
Dependencies are inferred from the claim text.